IRVINE, Calif.--(BUSINESS WIRE)--Allergan, Inc., (NYSE:AGN) today announced that the company has received approval from the U.S. Food and Drug Administration (FDA) to market JUVÉDERM VOLUMA™ XC, the ...
At 3 months, findings showed 80.4% of patients treated with Juvéderm Voluma XC achieved at least a 1-point improvement in moderate to severe temple hollowing. The Food and Drug Administration (FDA) ...
Oct. 02, 2024 8:00 AM ETAbbVie Inc. (ABBV) Per FDA requirement for this indication, Allergan Aesthetics is providing a product training program for providers, which includes facial anatomy and ...
(RTTNews) - Allergan plc (AGN) said that it received U.S. Food and Drug Administration approval for the use of Juvéderm VOLUMA XC, a hyaluronic acid gel dermal filler, with a TSK STERiGLIDE cannula ...
JUVÉDERM® VOLUX™ XC IS THE FIRST AND ONLY HYALURONIC ACID (HA) FILLER TO RECEIVE U.S. FDA APPROVAL FOR IMPROVING JAWLINE DEFINITION IRVINE, Calif., Aug. 3, 2022 /PRNewswire/ -- Today, Allergan ...
Years ago, the beauty industry began focusing on properly proportioned facial features. First in trend was cheekbone definition, then the trend became lip-focused. While these areas have been the ...
Juvéderm Volux XC is an injectable gel filler containing hyaluronic acid. The Food and Drug Administration (FDA) has approved Juvéderm ® Volux ™ XC for the improvement of jawline definition in ...
Tutorials on how to get a “snatched” look are all over TikTok, whether it’s via the siren eyes makeup technique or using concealer to sculpt your face. But Juvéderm just announced that it’s launching ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results